Cargando…

Fulminant type 1 diabetes after COVID-19 vaccination

Detalles Bibliográficos
Autores principales:	Tang, Xiaohan, He, Binbin, Liu, Zhenqi, Zhou, Zhiguang, Li, Xia
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier Masson SAS. 2022
Materias:	Letters to the Editor
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8786596/ https://www.ncbi.nlm.nih.gov/pubmed/35091092 http://dx.doi.org/10.1016/j.diabet.2022.101324

Ejemplares similares

“Preserved” glucagon secretion in fulminant type 1 diabetes
por: Murase‐Mishiba, Yuko, et al.
Publicado: (2018)

Fulminant myocarditis and COVID-19
por: Joob, Beuy, et al.
Publicado: (2020)

Case of fulminant type 1 diabetes with coronary microcirculatory dysfunction
por: Yamada, Hodaka, et al.
Publicado: (2014)

Response to “Preserved” glucagon secretion in fulminant type 1 diabetes
por: Takahashi, Nobuyuki, et al.
Publicado: (2018)

Glucagon secretions are impaired in patients with fulminant type 1 diabetes
por: Komada, Hisako, et al.
Publicado: (2019)

Case of fulminant type 1 diabetes mellitus associated with parvovirus B19 infection
por: Nishiumi, Tomoko, et al.
Publicado: (2014)

Fulminant myocarditis and COVID-19. Response
por: Irabien-Ortiz, Ángela, et al.
Publicado: (2020)

Characterization of immune checkpoint inhibitor-associated fulminant type 1 diabetes associated with autoantibody status and ethnic origin
por: Qiu, Junlin, et al.
Publicado: (2022)

Short‐term changes in pancreatic α‐cell function after the onset of fulminant type 1 diabetes
por: Takahashi, Nobuyuki, et al.
Publicado: (2018)

Nivolumab‐induced fulminant type 1 diabetes with precipitous fall in C‐peptide level
por: Miyauchi, Masaaki, et al.
Publicado: (2019)

Heart Transplantation to Fulminant Myocarditis during COVID-19 Outbreak
por: Wiwanitkit, Viroj
Publicado: (2020)

Fulminant myocarditis in COVID-19 and favorable outcomes with VA-ECMO
por: Bhardwaj, Abhishek, et al.
Publicado: (2022)

HSV1 viremia with fulminant hepatitis as opportunistic sequela in severe COVID-19
por: Roncati, Luca, et al.
Publicado: (2021)

Onset of fulminant type 1 diabetes mellitus under immunotolerance status after long‐term therapy for chronic inflammatory demyelinating polyneuropathy
por: Shigemoto, Ryo, et al.
Publicado: (2018)

Immunological Aspects of Fulminant Type 1 Diabetes in Chinese
por: Wang, Zhen, et al.
Publicado: (2016)

Author's Reply to Heart Transplantation to Fulminant Myocarditis during COVID-19 Outbreak
por: Kim, In-Cheol, et al.
Publicado: (2020)

Residual β-cell function after 10 years of autoimmune type 1 diabetes: prevalence, possible determinants, and implications for metabolism
por: Cheng, Jin, et al.
Publicado: (2021)

Fulminant parvovirus B19 myocarditis after chemotherapy: full recovery after antiviral therapy with tenofovir
por: Koenig, Tobias, et al.
Publicado: (2021)

An Unusual Case of Fulminant Type 1 Diabetes Developed during Puerperium
por: Shihabudheen, P., et al.
Publicado: (2021)

Progressive Fulminant Necrotizing Myelitis in COVID-19 Infection; Case Report of a Rare Complication
por: Azin, Hossein, et al.
Publicado: (2022)

Fulminant type 1 diabetes developed after influenza split vaccination
por: Sawamura, Toshitaka, et al.
Publicado: (2023)

Fulminant Supraglottitis from Neisseria meningitidis
por: Kortepeter, Mark G., et al.
Publicado: (2007)

Hemophagocytic lymphohistiocytosis after COVID-19 vaccination
por: Tang, Liang V., et al.
Publicado: (2021)

A pitfall in hemoglobin A1c measurement with high performance liquid chromatography method in the diagnosis of onset of fulminant type 1 diabetes mellitus
por: Oe, Yasuharu, et al.
Publicado: (2022)

New‐onset atypical fulminant type 1 diabetes after COVID‐19 vaccination: A case report
por: Kobayashi, Takaaki, et al.
Publicado: (2022)

Successful urgent liver transplant due to fulminant autoimmune hepatitis during the height of the COVID-19 pandemic in Spain()
por: Rodríguez-Gandía, Miguel A., et al.
Publicado: (2020)

Biventricular impella (BiPella) utilization in fulminant COVID-19 myopericarditis-mediated cardiogenic shock during pregnancy
por: Srichawla, Bahadar S., et al.
Publicado: (2023)

Guillain-Barré syndrome and fulminant encephalomyelitis following Ad26.COV2.S vaccination: double jeopardy
por: Stefanou, Maria Ioanna, et al.
Publicado: (2022)

Identification of hsa_circRNA_100632 as a novel molecular biomarker for fulminant type 1 diabetes
por: Yin, Wenfeng, et al.
Publicado: (2023)

Potentially irreversible olfactory and gustatory impairments in COVID-19: Indolent vs. fulminant SARS-CoV-2 neuroinfection
por: Vavougios, George D.
Publicado: (2020)

Could the development of COVID-19 vaccine-induced type 1 diabetes be explained by a simple mechanism?
por: Sasaki, Hironobu, et al.
Publicado: (2022)

Fulminant Cytotoxic Edema in a Patient with Pneumococcal Meningoencephalitis
por: Alonso, Angelika, et al.
Publicado: (2019)

SARS-CoV-2: a potential novel etiology of fulminant myocarditis
por: Chen, Chen, et al.
Publicado: (2020)

New-Onset Fulminant Type 1 Diabetes After SARS-CoV-2 Infection
por: Pan, Yunfei, et al.
Publicado: (2023)

Thyrotoxicosis after COVID-19 vaccination
por: Mungmunpuntipantip, Rujittika, et al.
Publicado: (2021)

Fulminant pneumatosis coli: A rare presentation of hollow viscus injury after blunt abdominal trauma
por: Waterland, Peter, et al.
Publicado: (2016)

Fulminant Myocarditis and Acute Appendicitis after COVID-19 Vaccination
por: Kawano, Hiroaki, et al.
Publicado: (2022)

Acute fulminant eosinophilic myocarditis due to Giardia lamblia infection
por: Beuy, Joob, et al.
Publicado: (2019)

Rapid visual loss associated with fulminant idiopathic intracranial hypertension
por: Saraswat, Neeraj, et al.
Publicado: (2019)

Acute Fulminant Encephalopathy in an Adult due to Ornithine Transcarbamylase Deficiency
por: Nambiar, Vivek K., et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_14bo9rt843rmm7eckvrth890cp